Company
NanoGhost
Harnessing the Natural Tropism of Mesenchymal Stem Cells to Cancer in A Drug Targeting Platform
Also known as nano-ghost.com
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
NanoGhost is a biotech company that develops a highly selective first-in-class drug targeting platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known tropism to cancer and sites of inflammation. NGs are nanovesicles equipped with inherent MSC targeting capabilities, ability to infiltrate inter and intra cellular niches, with versatile loading capacity and broad therapeutic applicability.
Products
- Web
- NG-1001
- Web
- NG-2001
- Web
- NG-3001
Loading relationship preview